JHVEPhoto/iStock Editorial via Getty Images Investment Outlook Amdocs Limited (NASDAQ:DOX) recently reported its FQ3 2024 financial results, matching revenue estimates by beating earnings expectations. I previously wrote about Amdocs in August 2023 with a Hold outlook due to revenue growth concerns and a full stock price valuation. While the company now has a record 12-month backlog of $4.25 billion, macroeconomic conditions continue to negatively pressure client spending and decisionmaking, resulting in li ...